Merus NV (STU:2GH) 5-Year EBITDA Growth Rate : -9.10% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Merus NV 5-Year EBITDA Growth Rate?

Merus NV's EBITDA per Share for the three months ended in Mar. 2024 was €-0.73.

During the past 3 years, the average EBITDA Per Share Growth Rate was -5.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -9.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Merus NV was 14.10% per year. The lowest was -63.40% per year. And the median was -6.60% per year.

Competitive Comparison of Merus NV's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Merus NV's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merus NV's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Merus NV's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Merus NV's 5-Year EBITDA Growth Rate falls into.

Merus NV 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Merus NV (STU:2GH) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Merus NV 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Merus NV's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Merus NV (STU:2GH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Merus NV (STU:2GH) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

MRUS:USA 2GH:Germany

Address

Uppsalalaan 17, Utrecht, NLD, 3584 CT

Website

https://www.merus.nl

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Merus NV (STU:2GH) Headlines

No Headlines